Business Context and Reporting Period
Company: Eastman Kodak Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1997
Reporting Date: November 14, 1997
Kodak reported results for the third quarter and first nine months of 1997. The company operates primarily in Consumer and Commercial Imaging segments. The period was marked by significant strategic shifts, including the acquisition of Wang Laboratories' software unit, the consolidation of Chinon Industries, and the initiation of a major cost-reduction program.
Key Financial Metrics
| Metric (in millions) | Q3 1997 | Q3 1996 | 9 Months 1997 | 9 Months 1996 |
|---|---|---|---|---|
| Total Revenues | $3,787 | $4,179 | $10,879 | $11,827 |
| Net Earnings | $232 | $410 | $749 | $1,124 |
| Earnings Per Share | $0.71 | $1.22 | $2.28 | $3.32 |
| Operating Cash Flow (9 Months) | $865 (1997) vs $1,449 (1996) | |||
| Cash & Equivalents (End of Period) | $310 (Sept 30, 1997) vs $1,777 (Dec 31, 1996) | |||
| Net Working Capital | $832 (Sept 30, 1997) vs $1,548 (Dec 31, 1996) | |||
| Total Debt (Short + Long Term) | $1,316 (Sept 30, 1997) vs $1,100 (Dec 31, 1996) |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 9% in Q3 and 8% year-to-date compared to 1996. This was largely driven by the sale of the Office Imaging business in late 1996 and unfavorable foreign currency exchange rates.
- Earnings Compression: Net earnings fell 43% in Q3 and 33% year-to-date. Earnings from operations dropped 31% in Q3 and 29% year-to-date.
- Segment Performance:
- Consumer Imaging: Sales were flat in Q3; earnings from operations dropped 21% due to lower selling prices and higher advertising costs (Advantix program).
- Commercial Imaging: Sales dropped 18% in Q3; earnings from operations plummeted 50% due to the Office Imaging divestiture, digital product write-offs, and R&D charges.
- Liquidity Shift: Cash and cash equivalents dropped significantly from $1.777 billion to $310 million, primarily due to a $732 million stock repurchase program and the $260 million acquisition of Wang Laboratories.
Guidance, Outlook, and Risks
Management Commentary and Unusual Items
- Acquisition Charges: Results included a $186 million pre-tax charge for purchased R&D related to the Wang Laboratories acquisition (Q1) and a $46 million pre-tax charge for the Image Technical Service (ITS) litigation reserve (Q3).
- Digital Product Losses: Losses on the digital products portfolio totaled approximately $150 million in Q3 and $300 million for the first nine months.
- Cost Reduction Initiative: On November 11, 1997, management announced a plan to reduce total costs by at least $1 billion over two years. This includes eliminating approximately 10,000 positions and a projected restructuring charge of at least $1 billion in Q4 1997.
- Outlook: Management indicated that full-year 1997 operating earnings per share could be as much as 25% below the adjusted 1996 level of $4.50.
Risks and Contingencies
- Legal Proceedings: The company faces ongoing antitrust litigation (ITS and related cases) regarding repair parts for copiers and micrographics equipment. A $46 million reserve was established following a 9th Circuit Court of Appeals decision.
- Environmental: Kodak is a potentially responsible party at approximately 20 Superfund sites, though management does not expect future costs to be material.
- Market Risks: Continued pressure from the strong U.S. dollar, price competition, and the pace of technological development in digital imaging.
Investor Verification Checklist
- Restructuring Impact: Verify the magnitude and timing of the $1 billion restructuring charge announced for Q4 1997 and its effect on full-year earnings.
- Digital Strategy Viability: Assess the sustainability of the $300 million loss in the digital products portfolio and the timeline for profitability.
- Liquidity Position: Monitor the cash balance ($310 million) relative to the $2 billion stock repurchase program and upcoming dividend obligations.
- Legal Exposure: Track the status of the ITS litigation appeal and potential additional liabilities from related antitrust cases.
- Foreign Currency Sensitivity: Evaluate the impact of exchange rate fluctuations on international sales, which offset volume growth in multiple segments.